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Structure of L-aspartate oxidase: implications for the succinate
dehydrogenase/fumarate reductase oxidoreductase family
Andrea Mattevi1*, Gabriella Tedeschi2, Luca Bacchella1, Alessandro Coda1,
Armando Negri2 and Severino Ronchi2
Background: Given the vital role of NAD+ in cell metabolism, the enzymes
involved in bacterial de novo NAD+ biosynthesis are possible targets for drug
design against pathogenic bacteria. The first reaction in the pathway is
catalysed by L-aspartate oxidase (LASPO), a flavoenzyme that converts
aspartate to iminoaspartate using either molecular oxygen or fumarate as
electron acceptors. LASPO has considerable sequence homology with the
flavoprotein subunits of succinate dehydrogenase (SDH) and fumarate
reductase (FRD).
Results: The crystal structure of the apoform of LASPO from Escherichia coli
has been determined to 2.2 Å resolution. The enzyme shows a novel fold for an
FAD-dependent protein, comprising a three-domain structure: an FAD-binding
domain with the dinucleotide-binding fold, a C-terminal three-helical bundle
domain, and an α+β capping domain, which is topologically similar to the small
subunit of spinach ribulose-1,5-bisphosphate carboxylase/oxygenase. The
interface between the FAD-binding and capping domains defines a cleft in
which the active site is located.
Conclusions: A number of strictly conserved residues present in all three
domains indicate that LASPO, SDH and FRD share the same overall folding
topology. Many of these conserved residues are in the FAD-binding site and
active centre, suggesting a similar catalytic mechanism. Thus, LASPO, SDH
and FRD form a class of functionally and structurally related oxidoreductases
that are all able to reduce fumarate and to oxidise a dicarboxylate substrate. 
Introduction
Quinolinic acid is the central metabolite for nicotinamide
adenine dinucleotide (NAD+) biosynthesis in all living
organisms, representing the precursor of the nicotinic
ring of NAD+ and related molecules. Differences exist
among organisms in the pathways for quinolinate produc-
tion. In eukaryotes, quinolinate is produced via the oxi-
dation of tryptophan, whereas in bacteria it is synthesised
via the condensation of iminoaspartate and dihydroxyace-
tone phosphate [1]. The pathway for de novo NAD+
biosynthesis is integrated with pathways for the salvage
and recycling of pyridine nucleotides, forming an inter-
twined metabolic network with several variations and dif-
ferences among organisms. Given the vital role of NAD+
in cell metabolism, it has been suggested that enzymes
involved in NAD+ biosynthesis and recycling might rep-
resent potential targets for antibiotics against pathogenic
bacteria [2]. Progress in the understanding of pyridine
nucleotide biosynthesis has been reviewed [1–4]. Fur-
thermore, the crystal structures of two enzymes involved
in NAD+ biosynthesis, NAD+ synthetase [5] and quino-
linic acid phosphoribosyltransferase [6], have been
recently reported.
L-Aspartate oxidase (LASPO) catalyses the first step in the
bacterial de novo biosynthesis of NAD+. The enzyme
carries out the oxidation of L-aspartate to iminoaspartate,
using flavine adenine dinucleotide (FAD) as noncovalently
bound prosthetic group [7,8]. The nadB gene coding for
Escherichia coli LASPO has been cloned [9] and overexpres-
sion of the protein has allowed the biochemical characteri-
sation of wild-type and mutant forms of the enzyme
[10–12]. E. coli LASPO consists of 540 amino acid residues
with a molecular mass of 60,354 Da. The catalytic cycle of
LASPO consists of a reductive half-reaction, in which the
FAD is reduced upon conversion of aspartate to iminoas-
partate, and an oxidative half-reaction, in which the FAD is
reoxidised. In this regard, LASPO is unusual with respect
to other members of the flavoprotein class of oxidases,
because it is able to use both oxygen and fumarate as elec-
tron acceptors for FAD oxidation. Thus, in addition to the
L-aspartate oxidase activity that produces iminoaspartate
and hydrogen peroxide, LASPO can also function as an 
L-aspartate/fumarate oxidoreductase, generating imino-
aspartate and succinate (Figure 1). This feature is likely to
be physiologically relevant as it allows LASPO to be func-
tional in both aerobic and anaerobic conditions [11].
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The amino acid sequences of LASPO from different
organisms have essentially no homology with FAD-depen-
dent enzymes of known three-dimensional structure, with
the exception of the N-terminal Gly-x-Gly-x-x-Gly motif
that is involved in the binding of the ADP portion of the
cofactor [10]. On the other hand, LASPO displays strong
homology with the flavoprotein subunits of fumarate
reductase (FRD) and succinate dehydrogenase (SDH).
These are complex membrane-bound multisubunit
systems, the flavoproteins of which can catalyse succinate
dehydrogenation and fumarate reduction coupled to elec-
tron transfer to or from other enzyme redox centres
[13,14]. Alignment of the sequences of LASPO, SDH and
FRD flavoproteins reveals a considerable degree of iden-
tity (~30%) and the presence of several conserved residues
[10]. These findings reflect the many functional proper-
ties shared by these enzymes, which are all able to catal-
yse fumarate reduction. On the other hand, unlike SDH
and FRD flavoproteins, LASPO is unable to oxidise succi-
nate. This feature reflects the low midpoint potential
(–0.216 mV) of the enzyme-bound FAD, which poses a
thermodynamic barrier against electron transfer from suc-
cinate to the flavin. On this basis, LASPO has been
described as a particular fumarate reductase unable to use
succinate as electron donor [12].
Here, we present the crystal structure of the apoform of
E. coli LASPO. This study was carried out in the frame-
work of two projects presently underway in our laboratory,
focused on flavin-dependent oxidases [15,16] and on the
structural biology of enzymes involved in NAD+ biosyn-
thesis [5,17]. The three-dimensional structure reveals that
LASPO combines the ‘classic’ dinucleotide-binding topol-
ogy [18] with two other domains that have no similarity to
other flavoproteins. Alignment of the LASPO, SDH and
FRD amino acid sequences, using knowledge of the
three-dimensional structure presented here, reveals the
location of conserved residues and leads to hypotheses
about their role in catalysis and substrate binding.
Results
Structure determination and quality of the final model
The three-dimensional structure of the apoform of
LASPO was solved by multiple isomorphous replacement
(MIR), followed by solvent flattening. The application of
the MIR method was hampered by the fact that all of the
heavy-atom derivatives identified had at least one
common site. In this respect, employment of the phasing
program SHARP [19] was absolutely essential for structure
elucidation. After crystallographic refinement, the final
model (Figures 2 and 3) has an R factor of 22.5% for
31,553 reflections to 2.2 Å resolution (no low-resolution or
σ cut-off was applied). The free R factor [20], calculated
using 1705 reflections omitted from the refinement, is
28.1% (Table 1). The final electron density is continuous
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Figure 1
The reactions catalysed by L-aspartate oxidase. The flavin is reduced by
L-aspartate and can be reoxidised by (a) molecular oxygen to generate
hydrogen peroxide or (b) fumarate, which is converted to succinate.
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Figure 2
Ramachandran plot for the LASPO structure. Nonglycine and glycine
residues are indicated by squares and triangles, respectively. (The
figure was produced with the program PROCHECK [52].)
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from Asn2 to Pro533, except for three protein segments
(residues 44–56, 104–141 and 411–413) which lack well-
defined density and were not included in the model.
These three segments are located on the protein surface:
the disorder of residues 44–56 is probably related to the
absence of bound FAD in the crystalline enzyme (see
below); residues 104–141 form part of a region known to
be highly susceptible to proteolysis [21]; and residues
411–413 belong to the linker connecting the FAD-binding
domain to the helical domain (Figures 3 and 4a). The
model displays good stereochemistry (Table 1); the
Ramachandran plot indicates that only two residues fall in
energetically disallowed regions (Figure 2). These amino
acids are Ser389, which is in well-defined density at the N
terminus of helix Fα6 (Figures 2 and 4a), and Ser417,
which is in a region with high atomic B factors on the
linker connecting the FAD-binding and helical domains
(Figure 2 and 4a). 
The overall structure
LASPO folds into three domains: the FAD-binding
domain (residues 2–241 and 353–410), the capping domain
(242–352) and the helical domain (414–533). The FAD-
binding domain is built up by a central five-stranded par-
allel β sheet (sheet A; Figures 4a and b) flanked on one
side by five α helices (Fα1, Fα2, Fα3, Fα4 and Fα6) and
on the other side by two antiparallel β sheets (sheets
B and C) and an α helix (Fα5). This topology resembles
the classic dinucleotide-binding fold observed in several
FAD-dependent enzymes [18].
Adjacent to the FAD-binding domain is the C-terminal
helical domain; the linker between the two domains is pro-
vided by a segment of extended polypeptide chain. The
helical domain consists of a three-helix bundle (Hα1, Hα2
and Hα3) with a down-up-down topology (Figure 4b).
Helices Hα1 and Hα2 are positioned on the surface of the
subunit, whereas Hα3 interacts with the FAD-binding
domain. The three helices tend to wrap around each other;
the angles between their axes are –166°, 25° and –149° for
Hα1 and Hα2, Hα1 and Hα3, Hα2 and Hα3, respectively.
This arrangement resembles that of a coiled coil, although
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Figure 3
Stereoview Cα trace of LASPO. Every 20th
Cα atom is labelled. 
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Table 1
Summary of restrained refinement.
Resolution (Å) 20.0–2.2
Number of reflections 31,553
R factor* 0.225
Number of reflections for Rfree 1705
Rfree 0.281
Number protein atoms 3761
Number of water molecules 197
Average atomic displacement parameters
whole protein (Å2) 41.7
FAD-binding domain (Å2) 39.3
capping domain (Å2) 52.0
helical domain (Å2) 39.1
water molecules (Å2) 44.9
Rms deviation from ideality†
1–2 distances (Å) 0.018
1–3 distances (Å) 0.045
Deviation in isotropic atomic 
displacement parameters†
1–2 mainchain (Å2) 2.0
1–3 mainchain (Å2) 3.1
1–2 sidechain (Å2) 2.5
1–3 sidechain (Å2) 3.5
*R factor = Σ|Fo–Fc|/Σ|Fo|, where Fo and Fc are the observed and
calculated structure-factor amplitudes, respectively. †1–2 distances are
for covalently bound atoms, whereas 1–3 distances refer to atoms
separated by two covalent bonds.
the amino acid sequences of the helices do not exactly
adhere to the heptad repeat that represents the coiled coil
hallmark [22]. The helical domain is completed by a C-ter-
minal extension, which forms a short β strand (HC3) that
runs antiparallel to strand FC1 of the FAD-binding
domain (Figures 4a and 4b).
The capping domain has a somewhat irregular structure. It
consists of a three-stranded antiparallel β sheet flanked by
four α helices. The domain is linked to the FAD-binding
domain by a two stranded β sheet (CD1 and CD2;
Figure 4b), and, apart from the linker residues, it makes
virtually no interactions with the rest of the protein. This
feature confers a bilobal shape on the protein, charac-
terised by an open cleft between the FAD-binding and
capping domains (Figure 4a). 
In solution, LASPO is in equilibrium between a
monomeric and a dimeric form [21]. The crystals used for
structure determination were grown under alkaline condi-
tions (pH 8.3), which is known to shift the equilibrium
towards dimer formation. Inspection of the crystal lattice
reveals the presence of a dimer formed by two protein
molecules packed around a crystallographic twofold axis
(Figure 4c). The surface area buried upon dimer formation
is 1200 Å2 (6% of the monomer accessible surface), which
falls in the range of values found in protein dimers of
known three-dimensional structure [23]. The intermolec-
ular contacts are formed mainly by residues from helices
Hα1 and Hα2 of the helical domain. In particular, none of
the residues involved in subunit–subunit interactions is
close to the active-site cleft, which is located between the
FAD-binding and capping domains. This observation is
consistent with the fact that both the monomeric and
dimeric forms of the enzyme are catalytically active [21],
thus implying that oligomerisation seems of no signifi-
cance for enzyme function.
Limited proteolysis experiments have been carried out on
both the holo and apoforms of the enzyme [21]. These
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Figure 4
The overall fold of LASPO. (a) The structure of the LASPO subunit.
FAD-binding, capping and helical domains are shown in red, cyan and
green, respectively. Residues 43–57, 103–142 and 410–414 are
linked by thin lines, because they are at the border of the disordered
polypeptide segments not included in the final model. Helices are
labelled by a letter indicating the domain (F for FAD-binding domain,
C for capping domain, H for helical domain), followed by their
sequential number (e.g. Fα1 is the first helix of the FAD-binding
domain). β Strands are named by a letter indicating the domain
followed by a letter labelling the β sheet and the sequential number
(e.g. FA1 is the first strand of β sheet A in the FAD-binding domain).
For clarity, the label of Fα4 has not been drawn. The N and C termini
are labelled. (b) Topology diagram for LASPO. (c) The LASPO dimer
viewed approximately along the twofold axis. With respect to (a), the
molecule has been rotated by 20° about the horizontal axis.
studies have shown that two major cleavage sites are
located at the peptide bonds 128–129 and 138–139, which
are both within the disordered region of residues 104–141
(Figure 4a). Furthermore, minor cleavage sites have been
identified at the peptide bonds 254–255 and 404–405,
which belong to linkers that connect the FAD-binding
domain to the capping and helical domains, respectively.
Such a pattern of proteolytic sites is fully consistent with
the three-domain architecture revealed by the LASPO
three-dimensional structure.
Structural similarity to other proteins
The program DALI [24] was used to compare the three-
dimensional coordinates of LASPO with those of all pro-
teins present in the February 1999 release of the
Brookhaven Protein Data Bank [25]. The search revealed
that each of the three LASPO domains has significant sim-
ilarity with other proteins, although the folding topologies
of the three domains were not found to coexist in any
other protein structure.
The FAD-binding domain shows clear similarity with
several proteins possessing the dinucleotide-binding fold
topology [18,26]. The top-scoring structure identified by
DALI is E. coli thioredoxin reductase [27] (TR), which
exhibits a similarity Z score [24] of 17.3 and a root mean
square (rms) deviation of 3.9 Å for 161 equivalent Cα
atoms (20% sequence identity for the superimposed
residues). Furthermore, the LASPO FAD-binding domain
displays considerable similarity with NADH peroxidase
[28] (Z = 16.8), human glutathione reductase [29]
(Z = 16.4), flavocytochrome c sulphide dehydrogenase [30]
(Z = 15.6), glucose oxidase [31] (Z = 15.5), p-hydroxyben-
zoate hydroxylase [32] (Z = 15.3), cholesterol oxidase [33]
(Z = 14.1), guanine nucleotide dissociation inhibitor [34]
(Z = 12.4), D-amino acid oxidase [35,36] (Z = 10.2) and
trimethylamine dehydrogenase [37] (Z = 9.6). With the
exception of the guanine nucleotide dissociation inhibitor
and trimethylamine dehydrogenase, all these proteins
bind FAD. In addition to these high-scoring structures,
DALI identified several other proteins that have a Ross-
mann fold topology and share some structural homology to
the FAD-binding domain. However, the degree of similar-
ity between LASPO and these proteins is considerably
lower: none of them display a similarity Z score above six.
The dinucleotide-binding fold is typically characterised by
a set of conserved elements, which includes a central
β sheet flanked by a β meander (sheet B in LASPO;
Figure 4a) and three α helices (Fα1, Fα4 and Fα6 in
LASPO). However, this basic scaffold can be decorated by
additional elements that vary among different flavoprotein
families and are often aimed at the construction of the cat-
alytic and substrate-binding sites (see [38,39] and refer-
ences therein). In the case of LASPO, two such additional
elements are present (Figures 4a and b): helices Fα2 and
Fα3 (residues 56–104), which are inserted between strands
FA2 and helix Fα4; and the capping domain (residues
242–352) inserted between strands FC1 and FC2. Remark-
ably, none of the proteins with structural homology to the
LASPO FAD-binding domain (see above) possesses a
domain that is topologically similar to the LASPO capping
domain. Moreover, none of them displays two helices that
are topologically equivalent to helices Fα2 and Fα3 of
LASPO. Thus, the topology of the excursions interspersed
in the basic dinucleotide-binding scaffold of LASPO
appears to be unprecedented, suggesting that LASPO rep-
resents a novel variation of the dinucleotide-binding motif.
The helical domain bears resemblance to several three-
helical bundle proteins. In particular, a search with DALI
shows that the most similar structure is that of enzyme
IIAlactose of the phosphoenolpyruvate:sugar phosphotrans-
ferase system from Lactococcus lactis [40] (Z score = 7.6).
Superposition of the LASPO helical domain and enzyme
IIAlactose results in an rms deviation of 2.4 Å for 72
Cα atoms (6% sequence identity).
As assessed using DALI, the only protein of known three-
dimensional structure to have notable topological similarity
to the capping domain of LASPO is spinach ribulose-1,5-
bisphosphate carboxylase/oxygenase (RUBISCO) [41].
Superposition of the small subunit of this enzyme with the
capping domain results in an rms deviation of 3.3 Å for
67 Cα atoms (9% sequence identity, Z = 3.3). The similar-
ity is confined to the central three-stranded β sheet (CE1,
CE2 and CE3; Figure 4b) and the surrounding Cα1 and
Cα2 helices; Cα3 and Cα4 are not present in RUBISCO,
being replaced by a short loop. The small subunit of
spinach RUBISCO is involved in subunit–subunit interac-
tions, but is not part of the catalytic centre. On the con-
trary, the LASPO capping domain contains several
residues (Figures 5 and 6) that line the active-site cleft.
FAD binding
The protein preparation used for crystallisation contained
the holoenzyme, having normal enzymatic activity. The
resulting crystals were invariably colourless, however,
even when an excess of FAD (~1 mM) was added to the
crystallisation medium. This suggested that the crystals
did not contain FAD bound to the protein. This feature
became unequivocally evident after structure determina-
tion. Despite careful checking of the MIR solvent-flat-
tened map and of the electron density calculated during
refinement, no bound FAD molecule could be identified.
Moreover, binding studies performed by soaking the crys-
tals in solutions containing saturating FAD concentrations
were unsuccessful. The present X-ray analysis thus refers
to the FAD-free apoform of the enzyme.
The FAD-binding site can be readily identified from the
comparison with other flavoproteins, however, because
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proteins displaying the dinucleotide-binding motif bind
FAD in a highly conserved manner [18,26]. On this basis,
the FAD-binding domain of E. coli TR [27] was superim-
posed onto the LASPO coordinates, considering that TR
was the top-scoring protein in the DALI [24] search for
structural homologues (see above). LASPO and TR were
superimposed using the secondary structure elements
forming the conserved core of the dinucleotide-binding
fold  (Figure 4b): the central β sheet (FA1, FA2, FA3, FA4
and FA5), the β meander (FB1, FB2 and FB3) and helices
Fα1, Fα4 and Fα6. The superposition resulted in an rms
deviation of 1.27 Å for 85 equivalent Cα atoms. Remark-
ably, it revealed that the FAD conformer present in E. coli
TR can be snugly fitted into the LASPO apoform struc-
ture, essentially requiring no conformational changes
(Figure 6). Only the sidechains of Ile219 and Asp223
needed some adjustment in order to avoid steric hindrance.
Such a modelling experiment based on the comparison of
LASPO and TR can only offer a few general clues about
the cofactor binding mode and does not allow an accurate
description of the FAD–protein interactions. Neverthe-
less, it effectively shows that binding of the cofactor ADP-
ribityl moiety in LASPO will be essentially identical to
that observed in other flavoproteins with the dinucleotide-
binding topology (see [38,39] and references therein). In
750 Structure 1999, Vol 7 No 7
Figure 5
                                                                       FA1       Fα1            FA2    
        -----------------------------------------------------d.........EEEE...HHHHHHHHHH.---....EEEE.......ddddddddddddd.--..HHH
LAS-ECO -----------------------------------------------------MNTLPEHSCDVLIIGSGAAGLSLALRLA---DQHQVIVLSKGPVTEGSTFYAQGGIAAVF--DETDS  62
LAS-MYC ----------------------------------------------------MAGPAWRDAADVVVIGTGVAGLAAALAADRA-GRSVVVLSKAAQTHVTATHYAQGGIAVVLP-DNDDS  66
LAS-BAC ----------------------------------------------------------MSKKTIAVIGSGAAALSLAAAFP---PSYEVTVITKKSVKNSNSVYAQGGIAAAY--AKDDS  57
FRD-ECO --------------------------------------------------------MQTFQADLAIVGAGGAGLRAAIAAAQANPNAKIALISKVYPMRSHTVAAEGGSAAVA--QDHDS  62
SUC-HUM MSGVRGLSRLLSARRLALAKAWPTVLQTGTRGFHFTVDGNKRASAKVSDSISAQYPVVDHEFDAVVVGAGGAGLRAAFGLS--EAGFNTACVTKLFPTRSHTVAAQGGINAALGNMEEDN 118
                                                                           * * * *  *                           * **          * 
            Fα2                   Fα3                                                          Fα4     FA3    FB1
        HHHHHHHHHHH......HHHHHHHHHHHHHHHHHHHH.....dddddddddd----ddddddddddddddddddddddddddd...HHHHHH...EEEE..EEEEEEEE...........
LAS-ECO IDSHVEDTLIAGAGICDRHAVEFVASNARSCVQWLIDQGVLFDTHIQPNGEE----SYHLTREGGHSHRRILHAADATGREVETTLVSKALNHPNIRVLERTNAVDLIVSDKIGLPGTRR 178
LAS-MYC VDAHVADTLAAGAGLCDPDAVYSIVADGYRAVTDLVGAGARLDESVPG--------RWALTREGGHSRRRIVHAGG----DATGAEVQRALQDAAGMLDIRTGHVALRVLHD-G------ 167
LAS-BAC IEAHLEDTLYAGCGHNNLAIVADVLHDGKMMVQSLLERGFPFDRNERG--------GVCLGREGAHSYNRIFHAGG---DATGRLLIDYLLKRINSKIKLIENETAADLLIEDG------ 160
FRD-ECO FEYHFHDTVAGGDWLCEQDVVDYFVHHCPTEMTQLELWGCPWSRRPDG--------SVNVRRFGGMKIERTWFAADKTGFHMLHTLFQTSLQ--FPQIQRFDEHFVLDILVDDG-----H 167
SUC-HUM WRWHFYDTVKGSDWLGDQDAIHYMTEQAPAAVVELENYGMPFSRTEDGKIYQRAFGGQSLKFGKGGQAHRCCCVADRTGHSLLHTLYGRSLR---YDTSYFVEYFALDLLMENG-----E 230
           *  **                          *   *                              *                    *                      *      
          FB2        FB3    FA4                       Fα5       FC1     CD1                Cα1     CE1        
        EEEEEEEE....EEEEEE..EEEE....................HHHHHHHH....EE....EEEEEEEE.....--......HHHHH...EEE...........------------...
LAS-ECO VVGAWVWNRNKETVETCHAKAVVLATGGASKVYQYTTNPDISSGDGIAMAWRAGCRVANLEFNQFHPTALYHPQA--RNFLLTEALRGEGAYLKRPDGTRFMPDF------------DER 284
LAS-MYC TAVTGLLVVRPDGCGIISAPSVILATGGLGHLYSATTNPAGSTGDGIALGLWAGVAVSDLEFIQFHPTMLFAGRAGGRRPLITEAIRGEGAILVDRQGNSITAGV------------HPM 275
LAS-BAC RCIGVMTKDSKGRLKVRHADEVVLAAGGCGNLFLHHTNDLTVTGDGLSLAYRAGAELTDLEFTQFHPTLLVKNGVS--YGLVSEAVRGEGGCLVDENGRRIMAER------------HPL 266
FRD-ECO VRGLVAMNMMEGTLVQIRANAVVMATGGAGRVYRYNTNGGIVTGDGMGMALSHGVPLRDMEFVQYHPTGLPGSGI-----LMTEGCRGEGGILVNKNGYRYLQDYGMGPETPLGEPKNKY 281
SUC-HUM CRGVIALCIEDGSIHRIRAKNTVVATGGYGRTYFSCTSAHTSTGDGTAMITRAGLPCQDLEFVQFHPTGIYGAGC-----LITEGCRGEGGILINSQGERFMERYAP-----------VA 334
                          *     * **        *      ***       *      ** * ***            *  *  ****  *    *                      
   
                   Cα2                CE2        Cα3     Cα4              CE3  CD2   FC2                     FA5
        .....HHHHHHHHHHHHHHH...------.EEEE.....HHHHHHH.HHHHHHHH.-.........EEEE.EEEEE..EEE........---------...EEE................
LAS-ECO GELAPRDIVARAIDHEMKRLGAD------CMFLDISHKPADFIRQHFPMIYEKLLG-LGIDLTQEPVPIVPAAHYTCGGVMVDDHGRTD---------VEGLYAIGEVSYTGLHGANRMA 388
LAS-MYC GDLAPRDVVAAAIDARLKATGDP------CVYLDARG--IEGFASRFPTVTASCRA-AGIDPVRQPIPVVPGAHYSCGGIVTDVYGQTE---------LLGLYAAGEVARTGLHGANRLA 377
LAS-BAC GDLAPRDIVSRVIHEEMAKGNRV------YIDFSAIS----DFETRFPTITAICEK-AGIDIHSGKIPVAPGMHFLMGGVSVNRWGETT---------VPGLYAIGETACSGLHGANRLA 366
FRD-ECO MELGPRDKVSQAFWHEWRKGNTISTPRGDVVYLDLRHLGEKKLHERLPFICELAKAYVGVDPVKEPIPVRPTAHYTMGGIETDQNCETR---------IKGLFAVGECSSVGLHGANRLG 393
SUC-HUM KDLASRDVVSRSMTLEIREGRGCG-PEKDHVYLQLHHLPPEQLATRLPGISETAMIFAGVDVTKEPIPVLPTVHYNMGGIPTNYKGQVLRHVNGQDQIVPGLYACGEAACASVHGANRLG 453
          *  ** *                                      *          * *      *  *  *   **                     ** * **      *****  
                  Fα6                                              Hα1                        Hα2
        .HHHHHHHHHHHHHHHHHHHHHddd.............--------...HHHHHHHHHHHHHHHHHHHHH......HHHHHHHHHHHHHHHHHHHHHH.....------.HHHHHHHHHH
LAS-ECO SNSLLECLVYGWSAAEDITRRMPYAHDISTLPPWDESR--------VENPDERVVIQHNWHELRLFMWDYVGIVRTTKRLERALRRITMLQQEIDEYYAHFRV------SNNLLELRNLV 494
LAS-MYC SNSLLEGLVVGGRAGKAAAAHAAAAGR-------SR-------------ATSSATWPEPISYTALDRGDLQRAMSRDASMYRAAAGLHRLCDSLSGAQVRDVA------CRRDFEDVALT 471
LAS-BAC SNSLLEALVFGKRAAEHIIQKPVYNRQYQSG------------------LETSVFYEVPDIEGHELQSKMTSHMSILREQSSLIELSIWLHTLPFQEVNVKDI------TIRQMELSHLW 462
FRD-ECO SNSLAELVVFGRLAGEQATERAATAGNGNEAAIEAQAAGVEQRLKDLVNQDGGENWAKIRDEMGLAMEEGCGIYRTPELMQKTIDKLAELQERFKRVRITDTSSVFNTDLLYTIELGHGL 513
SUC-HUM ANSLLDLVVFGRACALSIEESCRPGDKVPPIKPNAGEESVMN-LDKLRFADGSIRTSELRLSMQKSMQNHAAVFRVGSVLQEGCGKISKLYGDLKHLKTFDRGMVWNTDLVETLELQNLM 572
         ***    * *                                                                              *                        *     
          Hα3                                      HC3
        HHHHHHHHHHHH...................--------....EE..ddddddd--------------------------------------- 
LAS-ECO QVAELIVRCAMMRKESRGLHFTLDYPELLTH--------SGPSILSPGNHYINR--------------------------------------- 540
LAS-MYC LVAQSVTAAALARTESRGCHHRAEYPCTVPE--------QARSIVVRGADDANAVCVQALVAVC----------------------------- 527
LAS-BAC QTAKLMTFSALLREESRGAHFRTDFPHAEVS--------WQGRQIVHTKKGTKIRKNEGIWNNESFTAEKITESLFS---------------- 531
FRD-ECO NVAECMAHSAMARKESRGAHQRLDEGCTERDDVN----FLKHTLAFRDADGTTRLEYSDVKITTLPPAKRVYGGEADAADKAEAANKKEKANG 602
SUC-HUM LCALQTIYGAEARKESRGAHAREDYKVRIDEYDYSKPIQGQQKKPFEEHWRKHTLSYVDVGTGKVTLEYRPVIDKTLNEADCATVPPAIRSY- 664
          *      *  * **** *                                        Structure
Structure-based sequence alignment of E. coli LASPO with
representative enzymes of the succinate dehydrogenase/fumarate
reductase family. Residues that are conserved in all six aligned
sequences are marked with an asterisk. The letters ‘E’ and ‘H’ above
the sequences are used to indicate residues belonging to β strands
and α helices, respectively; residues not included in the final model are
indicated by the letter ‘d’. Five sequences are aligned: LASPO from
E. coli, LAS_ECO; LASPO from Mycobacterium tuberculosis,
LAS_MYC; LASPO from Bacillus subtilis, LAS_BAC; the flavoprotein
subunit of E. coli FRD, FRD_ECO; the flavoprotein subunit of human
SDH, SUC_HUM. 
particular, when LASPO with the modelled bound FAD is
inspected, it appears to possess all of the structural fea-
tures of the dinucleotide-binding fold [26]: the adenine
ring binding site is located in a well-defined pocket, sand-
wiched between the sidechains of Ile14 and Asn161; the
backbone atoms of Ala162 on strand FB1 are positioned to
form hydrogen bonds with the adenine ring; the loop
FA1–Fα1 containing the Gly-x-Gly-x-x-Gly motif [18]
and the N terminus of helix Fα1 (Figures 4b and 5) are
properly located to interact with the cofactor pyrophos-
phate group; and the sidechain carboxylate of Glu375 is a
potential hydrogen-bond partner for the 2′-hydroxyl group
of the FAD ribityl chain.
Mutagenesis studies have shown that residues Glu43,
Gly44, Ser45, Phe47 and Tyr48 (loop FA2–Fα2; Figure 4a)
take part in the binding of the cofactor isoalloxazine portion
[10]. These data are now corroborated by the observation
that in flavoproteins which have the dinucleotide-binding
fold, the flavin-binding site is often built by residues follow-
ing the strand topologically equivalent to FA2 of LASPO.
In the apoenzyme structure, residues 44–56 are disordered
and could not be located in the electron-density map
(Figures 4a and 5). Obviously, this fact conspires against the
possibility of having a complete view of the isoalloxazine-
binding site. However, superposition with TR shows that
the isoalloxazine of the modelled FAD is located in the
large cleft between the FAD-binding and capping domains.
In this position, the flavin N1–O2 locus falls close to the N
terminus of helix Fα6, as typically observed in FAD-depen-
dent enzymes with the dinucleotide-binding topology [42].
On this basis, it can be predicted that the flavin binds with
its re side facing strands CD1 and CD2, which connect the
capping and FAD-binding domains (Figure 7).
Binding of FAD to LASPO is relatively weak (dissociation
constant of 0.67 µM [10,11]) and the protein is normally
purified as a mixture of the holoenzyme and apoenzyme.
In this respect, dissociation of FAD from the crystalline
protein is not an exceptional phenomenon. Inspection of
the crystal packing shows that an intermolecular salt
bridge connects Glu43 with Arg80 of a symmetry-related
molecule. Replacement of Glu43 with arginine has a pro-
found effect on FAD binding, as it causes a twofold
increase in the cofactor dissociation constant and a sixfold
decrease in enzyme activity [10]. Taken together, these
findings suggest that crystal-packing forces may shift the
equilibrium towards the apoform, by affecting the confor-
mation of Glu43 and of neighbouring residues involved in
flavin binding (loop FA2–Fα2; Figures 4a and 6). In this
context, it should be noted that dissolving the crystals in
an FAD-containing 50 mM Hepes buffer (pH 8.0) results
in a normally active enzyme (data not shown). Thus, the
protein is able to bind FAD and regain activity, once
released from the crystal lattice.
A search of the current release of the Protein Data Bank
[25] shows that there are no known structures of an FAD-
dependent enzyme in the apoform. In this respect, the
crystal structure of LASPO provides an opportunity to
look at the consequences of cofactor dissociation on the
overall structure of the protein. The comparison with TR
and other dinucleotide-binding proteins indicates that
FAD removal is unlikely to cause large conformational
changes. In fact, the binding site for the cofactor ADP-
ribityl portion is possibly left unaltered by cofactor dissoci-
ation. Furthermore, limited proteolysis studies have
shown that the pattern of proteolytic digestion is essen-
tially the same in the holo and apoforms of the enzyme
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Figure 6
Stereoview backbone trace of the LASPO
monomer. The small black spheres depict Cα
atoms of residues that are conserved among
the LASPO, SDH and FRD sequences aligned
in Figure 5. A stick model of a bound FAD
molecule is included in order to illustrate the
position of its putative binding site. The position
of this site was identified by superimposition of
the TR and LASPO FAD-binding domains. The
resulting rotation and translation operators
were then applied to the FAD molecule bound
to the TR structure (see text). The orientation is
the same as in Figure 4a.
Structure
[21], supporting the notion that cofactor binding is not
associated with any major restructuring of the protein.
Homology with SDH and FRD
SDH and FRD are complex membrane enzymes that
consist of peripheral subunits, which are exposed to the
cytoplasm in bacteria and to the matrix in mitochondria,
and a variable number of integral membrane subunits.
The peripheral part of the enzyme is composed of an
iron–sulphur protein (containing three iron–sulphur clus-
ters) and a flavoprotein subunit, which catalyses succinate
oxidation and fumarate reduction [13,14]. Sequence analy-
sis indicates that the flavoprotein subunits of SDH and
FRD share considerable homology with LASPO [10,14]. A
structure-based sequence alignment (Figure 5) shows that
the homology extends throughout the protein sequence,
although it is higher in the FAD-binding and capping
domains. Thus, the sequence identity between E. coli
LASPO and E. coli FRD flavoprotein is 36.1% for the
FAD-binding domain, 36.3% for the capping domain and
26.9% for the helical domain. Similarly, the identity
between E. coli LASPO and the human SDH flavoprotein
is 31.8%, 37.9% and 21.2% for the FAD-binding, capping
and helical domains, respectively.
Alignment of the LASPO, SDH and FRD primary
sequences highlights the presence of several strictly con-
served residues (Figure 5). Analysis of the LASPO three-
dimensional structure shows that these conserved
residues can be grouped into three main regions
(Figure 6). The first and largest group of conserved
residues is positioned in the core of the FAD-binding
domain, where many conserved amino acids (Gly15,
Ala19, Ala203, Gly205, Asp223, Gly224, Ala372, Gly374
and Glu375) line the proposed binding site for the cofac-
tor ADP-ribityl moiety. Moreover, several conserved
residues are located at the beginning of Fα6, the N termi-
nus of which is expected to interact with the flavin moiety
(see above; Figures 5 and 7). In this regard, there is a
major difference between LASPO, SDH and FRD. The
prosthetic group of SDH and FRD is covalently attached
to the protein through a His–N(3)–flavin 8α linkage
[13,14]. In E. coli LASPO, the flavinylated histidine of
SDH and FRD is replaced by Ser45, which is positioned
in the FA2–Fα2 loop (Figure 5). This observation is in
perfect agreement with the prediction that the FA2–Fα2
loop, which is partly disordered in the LASPO apoenzyme
structure, directly interacts with the flavin when the
cofactor is bound to the protein.
The second cluster of conserved residues is located at the
top of the helical domain, where several conserved
sidechains (Ala504, Arg507, Glu509, Ser510, Arg511,
Gly512 and His514) interact with each other forming a
cluster of residues that are likely to be relevant for struc-
ture stabilisation. The helical domain represents the
region of lowest sequence similarity among the oxido-
reductases (Figure 5). Nevertheless, the existence of such
a conserved set of mutually interacting amino acids leads
to the prediction that the architecture of this C-terminal
domain is also conserved within this flavoprotein family.
A third group of conserved residues is formed by several
amino acids located on the surface of the capping domain
and on its linker to the FAD-binding domain (Figure 6).
Most of these sidechains are solvent-accessible, facing
the interdomain cleft in proximity of the flavin-binding
site. The positions of these residues in the LASPO
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Figure 7
The active centre in the LASPO apoenzyme
structure. The model of a bound FAD
molecule (see text and Figure 6) is drawn with
dashed lines to indicate the putative position
of the isoalloxazine ring. The secondary
structure elements shown are helix Fα6 and
strands CE3, CD1 and CD2. The dotted lines
indicate hydrogen bonds. The orientation is
the same as in Figure 4a.
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three-dimensional structure strongly indicate that they
form the enzyme active site (discussed below).
The active-site cleft
Chemical modification and site-directed mutagenesis
studies of the flavoprotein subunit of E. coli FRD have
identified His232 and Arg248 as residues that have a key
role in catalysis [43,44]. Replacement of His232 with
serine caused a decrease in the fumarate reductase activ-
ity, whereas substitution of Arg248 with leucine led to
nearly complete loss of catalytic turnover. The three-
dimensional structure of LASPO is consistent with these
findings. Arg263 of LASPO (equivalent to Arg248 in E. coli
FRD) is positioned on helix Cα1 of the capping domain
and points with its sidechain towards the active-site cleft.
Similarly, His244 (His232 in E. coli FRD) is located on
strand CD1, in proximity of the flavin-binding site
(Figure 7). Both residues are strictly conserved among the
LASPO, SDH and FRD sequences (Figure 5) and are bor-
dered in the three-dimensional structure by several con-
served amino acids. In particular, in addition to Arg263 and
His244, the active-site region contains two other conserved
arginine residues (Arg290 and Arg386) and a second con-
served histidine (His351). Remarkably, in the LASPO
structure these residues form a linear array of sidechains
running from helix Fα6, close to the flavin-binding site,
towards the capping domain. The order of the residues
along this array from Fα6 to the capping domain is Arg386,
His351, Arg290, His244 and Arg263 (Figure 7). The
closest contacts between these catalytic groups have been
determined: Arg386 NH1–His351 CD2,  3.0 Å, His351
CD2–Arg290 NH1, 5.3 Å; Arg290 NH2–His244 CD2,
4.1 Å; His244 CD2–Arg263 NH2, 7.2 Å.
The E. coli FRD mutagenesis data have been interpreted
in the context of a working model for the reaction mecha-
nism of fumarate reduction [43]. This model postulates that
arginine sidechains provide a ‘two-point’ attachment for the
substrate carboxylates, whereas a histidine residue is sup-
posed to have a role in protonating the substrate upon its
reduction. On the basis of the LASPO apoenzyme struc-
ture, it is impossible to assign a specific role to the residues
located in the active site cleft. Nevertheless, the presence
of three conserved arginine residues (Arg263, Arg290 and
Arg386) and two conserved histidine residues (His244 and
His351) in proximity of the putative flavin site is in keeping
with the proposed working model for the catalytic reaction.
Analysis of the LASPO three-dimensional structure shows
that the capping domain establishes almost no interactions
with the rest of the protein. It is conceivable that the
CD1–CD2 linker (Figure 4a) may act as a hinge, allowing
the capping domain to change its orientation with respect
to the rest of the structure. The idea that the capping
domain may be flexible is supported by the observation
that the average B factor of the capping domain atoms is
12 Å2 higher than that of the other protein atoms (Table 1).
Flavoenzymes are often equipped with flexible elements,
which typically have a role in controlling the accessibility
of the active site [16]. In the case of LASPO, the capping
domain seems well suited to fulfil a similar role, possibly
being able to adopt different conformations that might lead
to an opening and closing of the active-site cleft.
Biological implications
NAD+ and NADP+ are ubiquitous in nature and
perform crucial functions in a number of processes,
including redox reactions, DNA repair and protein
ADP-ribosylation. In living organisms, NAD+ levels are
controlled by a complex metabolic network, which
involves pathways for NAD+ biosynthesis and recycling.
These pathways vary substantially among different
organisms. Eukaryotes employ tryptophan oxidation to
produce quinolinic acid, which is the ‘building block’
for the synthesis of the nicotinic ring of NAD+ and
related compounds. In prokaryotes, quinolinic acid syn-
thesis proceeds via the condensation of aspartate and
dihydroxyacetone phosphate; this reaction is catalysed
by L-aspartate oxidase (LASPO) and quinolinate syn-
thase. Studies of de novo NAD+ biosynthesis are
presently being directed towards the mechanism of
action and the structural biology of the enzymes
involved. This knowledge may provide a route for the
development of antibiotics against pathogenic bacteria.
The metabolic role of LASPO is to provide iminoaspar-
tate for quinolinic acid production. In addition to this
role in NAD+ biosynthesis, LASPO is of interest as a
member of a group of FAD-dependent oxidoreductases,
which also includes the flavoprotein subunits of succi-
nate dehydrogenase (SDH) and fumarate reductase
(FRD). LASPO, SDH and FRD share considerable
sequence identity (30%) and several functional proper-
ties. These include the ability to catalyse fumarate reduc-
tion and to oxidise substrates bearing two carboxylate
groups. The structure of LASPO presented here is the
first structure of a member of this family of FAD-depen-
dent oxidoreductases.
The three-dimensional structure of LASPO consists of
three domains: an FAD-binding domain with the well-
known dinucleotide-binding fold, a three-helical bundle
domain, and an α+β capping domain. The active site is
located in a large cleft between the capping and FAD-
binding domains. Alignment of the LASPO, FRD and
SDH sequences reveals a set of strictly conserved
residues, these are mainly clustered in the FAD-binding
and active-site regions.
It has been suggested that LASPO and quinolinate syn-
thase, the first two enzymes in bacterial NAD+ biosyn-
thesis, form a multienzyme complex in which the labile
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iminoaspartate is directly channelled from LASPO to
the quinolinate synthase catalytic centre [1]. The combi-
nation of domain topologies displayed by LASPO has
not so far been observed in any other protein of known
three-dimensional structure. It will be interesting to see
whether such a three-domain organisation of the protein
is instrumental to the assembly of the postulated complex
with quinolinate synthase.
Materials and methods
Crystallisation
The protocol for the crystallisation of LASPO has been described pre-
viously [45]. Briefly, the crystals were grown by the hanging-drop
vapour-diffusion technique using protein solutions containing
~100 mg/ml protein in 20 mM Hepes (pH 8.0) and reservoirs consist-
ing of 12–14% w/v PEG 4000, 100 mM sodium acetate, 100 mM
Tris/HCl (pH 8.3) at 22°C. The crystals belong to space group P3221
with unit-cell parameters a = b = 84.9 Å, c = 159.9 Å, α = β = 90°,
γ = 120°. There is one subunit in the asymmetric unit.
The protein used for crystallisation had normal activity and the typical
yellow colour. However, the LASPO crystals resulting from these
experiments were colourless, indicating that they did not contain oxi-
dised FAD. Indeed, during the course of structure determination it
became evident that no cofactor was bound to the crystalline enzyme.
For this reason, crystallisation experiments were carried out adding
FAD (up to 1 mM) together with other protein ligands, such as succi-
nate and fumarate, known to decrease the FAD dissociation constant
[10]. However, even under these conditions, all crystals obtained
turned out to be colourless.
Data collection
For soaking and data collection, the crystals were harvested in a solu-
tion containing 20% w/v PEG 4000, 100 mM sodium acetate and,
100 mM Tris/HCl (pH 8.3). All diffraction experiments were carried out
under cryogenic conditions (100K). For this purpose, the crystals were
soaked for a few seconds in a cryoprotected solution consisting of
25% v/v glycerol, 20% w/v PEG 4000, 100 mM sodium acetate and
100 mM Tris/HCl (pH 8.3). Data were collected using a rotating-anode
X-ray generator equipped with a graphite monochromator and an
Raxis-IIc imaging plate detector. Furthermore, a native and para-
chloromercuriphenyl sulphonic acid (PCMBS) derivative data set were
measured at the ID14-EH3 beamline of the European Synchrotron
Radiation Facility (ESRF), using a MarCCD detector. MOSFLM (written
by AGW Leslie) and the CCP4 [46] suite of programs were used to
index and merge each individual data set (Table 2).
MIR phasing
A search for derivatives revealed that several heavy-atom compounds
were able to bind to the crystalline protein. Derivatives were obtained
by soaking crystals in PCMBS, K2OsO4, KI, TaCl3, K2WO4 and
K2PtCl6. However, these derivatives were poorly isomorphous to the
native crystals and all shared one or two common sites (close to Cys93
and Cys195). Thus, heavy-atom refinement with MLPHARE [46]
always resulted in essentially uninterpretable maps. In this regard,
usage of the program SHARP [19] represented a breakthrough in the
phasing process, by providing maps of drastically superior quality. The
best results were obtained when the in-house collected OsO4,
PCMBS and KI derivative data were combined with the native and
PCMBS derivative data collected at the ESRF. The two PCMBS data
sets were treated individually, as two ‘crystals’ of the same ‘compound’,
following SHARP terminology. In particular, the synchrotron measured
PCMBS derivative was used as reference data set for SHARP calcula-
tions. This improved the map quality, probably because it allowed a
better estimate of the lack-of-isomorphism parameters. The MIR
phases were refined and extended to 2.2 Å by SOLOMON [47]
solvent flipping. A summary of data collection and MIR phasing statis-
tics is presented in Table 2.
Model building and refinement
An initial model was built in the SHARP/solvent-flipped map using the
program O [48]. In parallel to manual building, the program wARP
[49] was used to attempt automatic model tracing. Remarkably, wARP
was able to automatically trace virtually all residues of the FAD-binding
and helical domains, although it failed with the capping domain possi-
bly due its high average B factor (Table 1). Thus, wARP was useful in
that it confirmed chain tracing and fitting of the amino acid sequence
in the density.
The crystallographic refinement was carried out using the maximum-
likelihood program REFMAC [50] coupled to ARP [51], which was
used to add water molecules automatically. Various refinement 
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Table 2
Data collection and phasing.
Crystal Native Derivative PCMBS* Derivative PCMBS* Derivative KI Derivative K2OsO4
Source ESRF† ESRF† CuKα CuKα CuKα
ID14-EH3 ID14-EH3
Soaking conditions – 0.5 mM, 0.5 h 1 mM, 0.5 h 6 mM, 12 h 6 mM, 24 h
Resolution (Å) 2.2 2.4 3.0 2.7 3.1
Data redundancy 3.8 4.9 3.5 3.4 3.1
Completeness (%) 96.9 (87.4) 99.2 (99.6) 95.5 (76.1) 96.3 (92.4) 99.5 (99.4)
Number of reflections 33,258 25,351 13,708 18,342 12,100
Rmerge‡ 0.049 (0.14) 0.075 (0.28) 0.084 (0.16) 0.088 (0.24) 0.101 (0.33)
Rderiv§ – 0.19 0.19 0.18 0.15
RCullis# – 0.41 0.76 0.65 0.59
Phasing power¶ – 3.7 0.6 1.9 2.4
Number of sites – 4 4 2 2
Values in parentheses refer to the highest resolution shell. *PCMBS, 
p-chloromercuriphenyl sulfonic acid. †ESRF, European Synchrotron
Radiation Facility. ‡Rmerge = ΣIj – <Ij> /Σ <Ij>, where Ij is the
intensity of an observation of reflection j and <Ij> is the average
intensity for reflection j. §Rderiv = ΣFPH–FP/ΣFP, where FPH is
the structure factor for the derivative and FP is the structure factor of
the native crystal. #RCullis = ΣFPH ± FP–FH/ΣFPH ± FP, where
FPH and FP are defined as above and FH is the calculated heavy-atom
structure factor. Centric reflections only were included for this
calculation. ¶Phasing power = the root mean square heavy-atom
structure-factor amplitude divided by the lack of closure.
protocols, including unrestrained REFMAC/ARP refinement, were tried
in order to localise the regions 44–56 and 104–141. However, these
residues could not be located in the density, thus suggesting that they
are disordered. The final R factor and Rfree [20] are 22.5% and 28.1%,
respectively, for all data within the 20.0–2.2 Å resolution range. The
results of the refinement are summarised in Table 1.
All calculations relating to model validation, model analysis and
structure comparisons were carried out with PROCHECK [52], DALI
[24], the programs of the CCP4 suite [46] and of the ‘Uppsala Soft-
ware Factory’ [53]. Drawings were generated with the programs
MOLSCRIPT [54] and BOBSCRIPT [55].
Accession numbers
The coordinates and structure factors of LASPO have been deposited
in the Protein Data Bank with accession codes 1chu and r1chusf,
respectively.
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